Your browser doesn't support javascript.
loading
Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer.
Sharma, Nitya V; Pellegrini, Kathryn L; Ouellet, Veronique; Giuste, Felipe O; Ramalingam, Selvi; Watanabe, Kenneth; Adam-Granger, Eloise; Fossouo, Lucresse; You, Sungyong; Freeman, Michael R; Vertino, Paula; Conneely, Karen; Osunkoya, Adeboye O; Trudel, Dominique; Mes-Masson, Anne-Marie; Petros, John A; Saad, Fred; Moreno, Carlos S.
  • Sharma NV; Genetics and Molecular Biology PhD Program, Emory University, Atlanta 30322, Georgia. nvsharm@emory.edu.
  • Pellegrini KL; Department of Urology, Emory University School of Medicine, Atlanta 30322, Georgia. kathryn.pellegrini@emory.edu.
  • Ouellet V; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. veronique.ouellet.chum@ssss.gouv.qc.ca.
  • Giuste FO; MSTP/MD PhD, Emory University, Atlanta 30322, Georgia. fgiuste@emory.edu.
  • Ramalingam S; Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. selkorner@yahoo.com.
  • Watanabe K; Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. kenneth.a.watanabe@emory.edu.
  • Adam-Granger E; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. oxalique@live.com.
  • Fossouo L; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)/Institut du cancer de Montréal, Montreal, QC H2X 0A9, Canada. lufossouo@yahoo.ca.
  • You S; Division of Cancer Biology and Therapeutics, Departments of Surgery & Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. sungyong.you@cshs.org.
  • Freeman MR; Division of Cancer Biology and Therapeutics, Departments of Surgery & Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. michael.freeman@cshs.org.
  • Vertino P; Department of Radiation Oncology, Emory University School of Medicine, Atlanta 30322, Georgia. pvertin@emory.edu.
  • Conneely K; Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. pvertin@emory.edu.
  • Osunkoya AO; Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. kconnee@emory.edu.
  • Trudel D; Department of Human Genetics, Emory University, Atlanta 30322, Georgia. kconnee@emory.edu.
  • Mes-Masson AM; Department of Urology, Emory University School of Medicine, Atlanta 30322, Georgia. adeboye.osunkoya@emory.edu.
  • Petros JA; Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta 30322, Georgia. adeboye.osunkoya@emory.edu.
  • Saad F; Winship Cancer Institute of Emory University, Atlanta 30322, Georgia. adeboye.osunkoya@emory.edu.
  • Moreno CS; Atlanta VA Medical Center, Decatur, GA 30033, USA. adeboye.osunkoya@emory.edu.
Cancers (Basel) ; 10(10)2018 Oct 11.
Article en En | MEDLINE | ID: mdl-30314329
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2018 Tipo del documento: Article